Last reviewed · How we verify
NCT04900051
Clinical Efficacy and Safety of Fecal Microbiota Transplantation
trial in Fecal Microbiota Transplantation in 100 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Keimyung University Dongsan Medical Center |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 24 December 2020 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across South Korea |
Conditions studied
- Fecal Microbiota Transplantation — all drugs for Fecal Microbiota Transplantation →
Sponsor
Keimyung University Dongsan Medical Center
Who can join
Adults 18 to 80, any sex, with Fecal Microbiota Transplantation. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Changes in the fecal microbiota are known to be involved in the etiology of several diseases. The purpose of this study is to evaluate the effectiveness and safety of fecal microbiota transplantation (FMT) in diseases known to be associated with intestinal microbial inbalance. .
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT04900051
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fecal Microbiota Transplantation
Currently open trials in the same condition.
- NCT06282952 — Health Outcomes in C-Section Infants With Fecal Microbiota Transplantation · NA · recruiting
- NCT07149441 — Efficacy and Mechanism of FMT in the Treatment of Inflammatory Bowel Disease: an Open-label Randomized Controlled Study · NA · active not recruiting
- NCT06920212 — Clinical Safety and Efficacy of Fecal Microbiota Transplantation (FMT) in the Treatment of Alzheimer's Disease · NA · active not recruiting
- NCT05790356 — Fecal Microbial Transplantation for Rheumatoid Arthritis Trial · NA · recruiting
- NCT06782880 — Fecal Microbiota Transplantation for the Prevention of Infectious Complications After Liver Transplantation · NA · recruiting
Other Keimyung University Dongsan Medical Center trials
Trials by the same sponsor.
- NCT06963424 — Pain Relief and and Peripheral Perfusion Index During Erector Spinae Block · NA · completed
- NCT06471907 — Comparison of Pain Relief and Peripheral Perfusion Index · NA · recruiting
- NCT07210073 — Video Education to Improve Blood Pressure Control in Patients With Ischemic Heart Disease and Hypertension (V-EDUCATE) · NA · completed
- NCT06149299 — Great Occipital Nerve Block Using Different Approach · NA · unknown
- NCT05705362 — Simple Crossover Versus Side Branch Opening in Patients With Non-Left Main Bifurcation Lesion · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04900051 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Keimyung University Dongsan Medical Center
- Last refreshed: 25 May 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04900051.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing